Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-18 | 2021-11-16 | CBIO | Andrews Patricia S | Dir | P - Purchase | $2.05 | +40.0K | 45.2K | +762% | +$82.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | P | A | 40,000 | $2.05 | 45,250 | D | — | — | (F1) The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.03 to $2.07 per share, with a weighted average purchase price of $2.05 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |